NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MEDADVISOR LIMITED (MDR)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
MEDADVISOR LIMITED30/11/2015
EXALT RESOURCES LIMITED30/11/2015

Shareholder links

Our website ranking of MDR: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MDR6
Address: Level 4, 969 Burke Road CAMBERWELL VIC 3124
Tel:  +61 (03) 9095 3036Fax: + 61 (03) 9428 4664

Date first listed: 26/05/2011

Sector: Health Care Equipment & Services Industry Group: XMJ
Activities: E-healthcare software developer

News & Events

Expand this box to read and print

The suspension of trading in the securities of MedAdvisor Limited will be lifted immediately, following the release by MDR of an announcement regarding the outcome of the Placement and the institutional component of the Entitlement Offer.

12/11/2020

MedAdvisor successfully completes placement and institutional entitlement offer with $35 million to acquire US-based Adheris Health.

12/11/2020

The company requests that a further voluntary suspension of the company's securities from the commencement of trading on 10 November 2020 until the earliest of such time as the company makes an announcement in relation to the outcome of the institutional component of the offer; the opening of trading on 12 November 2020; and the company separately requests that the voluntary suspension be lifted.

10/11/2020

The company requests a further voluntary suspension of its securities from the commencement of trading on 10 November 2020 until the earliest of: such time as the company makes an announcement to the market in relation to the outcome of the institutional component of the offer; the open of trading on 12 November 2020; and the company separately requests that the voluntary suspension be lifted.

10/11/2020

The company releases a cleansing notice in respect of accelerated non-renounceable pro-rata entitlement offer.

06/11/2020

The company releases an investor presentation update on the Adheris acquisition.

06/11/2020

The company has adjusted the price for the capital raise as it forges ahead to acquire US-based Adheris Health. MedAdvisor has elected to price the deal at 38 cents which is expected to allow the company to attract a broader cohort of new strategic investors to the register. The maximum amount that MedAdvisor may raise under the placement is approximately AUD $23.5M. The maximum amount that MedAdvisor may raise under the entitlement offer is approximately AUD $37.7M.

06/11/2020

The securities of MedAdvisor Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of MDR, pending the release of an announcement regarding an acquisition and a capital raising.

06/11/2020

we understand that on or about this date the company consolidated its shares 1 for 7

28/11/2019

The securities of MedAdvisor Limited (formerly Exalt Resources Limited) (the "Company") will be reinstated to official quotation from the commencement of trading on Tuesday 1 December 2015, following the Company's compliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. 387,406,652 fully paid ordinary shares Security Code: MDR

30/11/2015

name changed from Exalt Resources Limited

30/11/2015

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    08/11/2023Jim Xenos-6,846,955$0.180$1,232,452
    17/11/2021Jim Xenos-6,846,955$0.360$2,464,904
    27/06/2017Peter Bennetto15,000$0.280$4,200
    15/03/2017Jim Xenos300,000$0.032$9,630
    15/03/2017Peter Bennetto200,000$0.032$6,400

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Linda JenkinsonNon Exec Chairman28/02/2022
    Rick RatliffManaging Director, CEO18/07/2022
    Ruba El-AfifiCOO10/08/2021
    Ancila DesaiCFO, Company Secretary17/10/2022
    Sandra HookNon Exec Director19/01/2016
    Kevin HutchinsonNon Exec Director23/11/2022
    Kate HillNon Exec Director24/05/2023
    Lucas MerrowNon Exec Director10/08/2021
    Anthony TassoneNon Exec Director27/07/2022
    Brett MagunNon Exec Director24/05/2023
    Jim XenosDirector
    Anshu RaghuvanshiCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    RaeAnn GrossmanNon Exec Director01/02/202221/04/2023
    Robert ReadExecutive Director30/11/2022
    Annabelle GrantCFO15/07/202217/10/2022
    Josh SwinnertonExecutive Director12/11/201527/07/2022
    Simon GloverCFO31/07/201915/07/2022
    Chris RiddNon Exec Chairman18/02/202028/02/2022
    Peter BennettoNon Exec Director28/11/201326/11/2021
    Jeffrey ShermanNon Exec Director14/10/201930/04/2021
    Richard SheridanCFO25/02/201331/07/2019
    Carlo CampicianoCFO31/07/2019
    Peter DykesNon Exec Director30/11/201214/11/2015
    Stephen BrockhurstDirector04/05/201512/11/2015
    Shane HartwigNon Exec Director21/07/201004/05/2015
    Robert WhittonNon Exec Chairman30/11/201228/11/2013
    Romy SoekarnoIndependent Director23/08/201228/11/2013
    Robert CrossmanNon Exec Director23/07/201325/11/2013
    Edward FooIndependent Director30/11/201211/11/2013
    Barry TudorCEO, Managing Director03/05/201217/09/2013
    Emmanuel CorreiaExecutive Chairman21/07/201030/11/2012
    Jim MaloneNon Exec Director15/02/201130/11/2012

    Date of first appointment, title may have changed.